Lianjun Zhang

5PUBLICATIONS
35CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsGene and molecular therapyHaematologyHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 26, 2026
Inhibition of ADSS2-mediated de novo AMP biosynthesis re-sensitizes acute myeloid leukemia to BH3 mimetics.

|May 12, 2026
Targeting PRMT9 Overcomes Venetoclax Resistance in AML by Modulating Splicing and Inhibiting Translation.

|Apr 14, 2026
Allosteric inhibition of RAN decreases miR-126 biogenesis in endothelial cells and controls acute myeloid leukemia growth.

Melissa Valerio, Wenyuan Wei, Hyunjun Kang

|Dec 15, 2025
Pharmacological inhibition of miR-126 enhances venetoclax activity in acute myeloid leukemia.

Lianjun Zhang, HyunJun Kang, Melissa Valerio

|Feb 05, 2025
Targeting RNA modification and mitochondrial metabolism cross talk in leukemic stem cells with CDK7 inhibitor TGN-1062.

Hyunjun Kang, Lianjun Zhang, Mohan R Kaadige

Pageof 1

Frequent Collaborators

4 joint publications

Ya-Huei Kuo

2 joint publications

Le Xuan Truong Nguyen

2 joint publications

Guido Marcucci

2 joint publications

J Jefferson P Perry